BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1281204)

  • 1. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
    Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
    Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
    Hirano T; Manabe T; Tobe T
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
    Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
    Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats.
    Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T
    Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
    Hirano T; Manabe T; Tobe T
    Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
    Hirano T; Manabe T; Tobe T
    Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis.
    Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T
    Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats.
    Wang ZH; Manabe T; Ohshio G; Hirano T; Okada N; Imamura T; Kawaguchi Y; Yotsumoto F; Yamaki K; Imamura M
    Arzneimittelforschung; 1995 Oct; 45(10):1082-6. PubMed ID: 8595064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic injuries in rats with fecal peritonitis: protective effect of a new synthetic protease inhibitor, sepinostat mesilate (FUT-187).
    Hirano T
    J Surg Res; 1996 Mar; 61(2):301-6. PubMed ID: 8656599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
    Hirano T; Manabe T
    J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of lysosomal and digestive enzymes in rat caerulein pancreatitis].
    Hirano T; Manabe T; Imanishi K; Tobe T
    Nihon Geka Hokan; 1991 Mar; 60(2):122-34. PubMed ID: 1726396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
    Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
    Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
    Hirano T; Manabe T; Tobe T
    J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of parotid gland in rat caerulein-induced acute pancreatitis: study on in vitro system].
    Hirano T; Manabe T; Tobe T
    Nihon Geka Hokan; 1990 Jul; 59(4):310-4. PubMed ID: 1718233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
    Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
    Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of cyclosporin A on the exocrine pancreas in rats.
    Hirano T; Manabe T; Printz H; Tobe T
    Surg Gynecol Obstet; 1992 Dec; 175(6):495-500. PubMed ID: 1280373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
    Dabrowski A; Gabryelewicz A
    J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal enzyme secretion into pancreatic juice in rats injected with pancreatic secretagogues and augmented secretion after short-term pancreatic duct obstruction.
    Hirano T
    Nihon Geka Hokan; 1994 Jan; 63(1):21-35. PubMed ID: 7529987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123.
    Hirano T; Manabe T
    Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypothermia on pancreatic acinar cells in rats.
    Hirano T; Manabe T; Calne R; Printz H
    Nihon Geka Hokan; 1992 Jul; 61(4):320-33. PubMed ID: 1281973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.